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Purpose: Whole body periodic acceleration (WBPA) with a horizontal motion platform augments intravascular pulsatile shear stress with a release 
of nitric oxide and improves vascular endothelial function. We hypothesized that treatment with WBPA reverses left ventricular (LV) remodeling as a 
result of increased coronary and peripheral vasodilatory reserve in angina patients with old myocardial infarction (MI).
Methods: Twenty-six angina patients [68 ± 10 (SD) years] with old MI who were not indicated for PCI and/or CABG were randomly assigned to 
remain sedentary (Sedentary group: SE group, n = 13) or to undergo 20 sessions of WBPA with the motion platform for 4 weeks (WBPA group, n = 
13). WBPA was applied at 2 to 3 Hz and approximately ±2.2 m/sec2 for 45 min. We repeated the symptom-limited treadmill exercise test using the 
standard Bruce protocol along with adenosine sestamibi myocardial scintigraphy.
Results: In the WBPA group, the exercise time until 0.1 mV ST depression increased from 4.4 ± 2.1 to 6.4 ± 2.7 min (p<0.05), and the double 
product at 0.1 mV ST depression from 15,400 ± 3,500 to 17,400 ± 3,500 mmHg·beats/min (p<0.05). These findings suggest that the treatment 
ameliorates exercise capacity as a result of both central and peripheral effects. In resting scintigraphic images, LV end-diastolic volume index 
decreased from 73 ± 38 ml/m2 to 60 ± 27 ml/m2 (p<0.05), with a significantly augmented LV ejection fraction from 50 ± 16 % to 55 ± 16 % 
(p<0.05). These findings indicate the reverse of the LV remodeling after MI. The severity score of myocardial scintigraphy during adenosine infusion 
decreased from 20 ± 10 to 14 ± 8 (p<0.05), resting severity score also decreased from 13 ± 10 to 8 ± 10 (p<0.05), indicating that size of both the 
ischemic and hibernating myocardium became smaller. In contrast, all aforementioned parameters remained unchanged in 13 sedentary patients 
receiving only convention medical treatment.
Conclusions: Treatment with WBPA for angina patients ameliorates exercise capacity, myocardial ischemia and LV remodeling through central and 
peripheral effects. The development of such a therapeutic modality will open a new field of the treatment of angina patients with old MI.
